Hoofddorp, Netherlands – February 5, 2026 – Nordic Group B.V., an international pharmaceutical company operating as Nordic Pharma, announced today the introduction of Lacrifill®, a novel therapy for dry eye, to the European market. Following CE mark approval in 2025, Lacrifill® is now available to healthcare professionals and patients across a range of European markets, marking a major step in […]